Atlas Trials

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of E2730 in Healthy Participants

Clinical trial NCT03451890 · COMPLETED

Trial details

NCT number
NCT03451890
Sponsor
Eisai Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Participants
Start date
2018-02-09
Primary completion
2018-09-26
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.